These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12064189)

  • 41. [Anticoagulation therapy in paroxysmal atrial fibrillation].
    Risøe C; Gjesdal K
    Tidsskr Nor Laegeforen; 2004 Apr; 124(7):950-2. PubMed ID: 15060644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
    Tran H; McRae S; Ginsberg J
    Cardiol Clin; 2008 May; 26(2):235-50, vi-vii. PubMed ID: 18406997
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Oral anticoagulation treatment--control, risks, benefits, and informed consent].
    Froom P; Hermoni D; Barak M
    Harefuah; 2003 Jan; 142(1):56-60, 77. PubMed ID: 12647491
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.
    Partington SL; Abid S; Teo K; Oczkowski W; O'Donnell MJ
    Thromb Res; 2007; 120(5):663-9. PubMed ID: 17434577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Periprocedural management of anticoagulation in patients on extended warfarin therapy.
    Jafri SM; Mehta TP
    Semin Thromb Hemost; 2004 Dec; 30(6):657-64. PubMed ID: 15630672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term management of patients after venous thromboembolism.
    Kearon C
    Circulation; 2004 Aug; 110(9 Suppl 1):I10-8. PubMed ID: 15339876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of oral anticoagulant therapy in the real practice of an anticoagulation clinic: focus on atrial fibrillation.
    Poli D; Antonucci E; Lombardi A; Cecchi E; Gensini GF; Abbate R; Prisco D
    Blood Coagul Fibrinolysis; 2005 Oct; 16(7):491-4. PubMed ID: 16175008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reducing the risk for stroke in patients who have atrial fibrillation.
    Garcia DA; Hylek E
    Cardiol Clin; 2008 May; 26(2):267-75, vii. PubMed ID: 18406999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 51. The optimal duration of anticoagulant therapy for venous thrombosis.
    Hirsh J
    N Engl J Med; 1995 Jun; 332(25):1710-1. PubMed ID: 7760874
    [No Abstract]   [Full Text] [Related]  

  • 52. Current Indian scenario on the use of oral anticoagulants.
    J Assoc Physicians India; 2014 Jun; 62(6 Suppl):28-9. PubMed ID: 25845125
    [No Abstract]   [Full Text] [Related]  

  • 53. [The anticoagulant management in patients with heart valve prosthesis].
    Ibarra-Pérez C; Argüero R
    Prensa Med Mex; 1973; 38(1):17-9. PubMed ID: 4745921
    [No Abstract]   [Full Text] [Related]  

  • 54. Management of oral anticoagulant therapy in Italy.
    Berrettini M; Agnelli G
    Semin Thromb Hemost; 1999; 25(1):27-31. PubMed ID: 10327217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of oral anticoagulation in patients undergoing minor dental procedures.
    Alaali Y; Barnes GD; Froehlich JB; Kaatz S
    J Mich Dent Assoc; 2012 Aug; 94(8):36-41. PubMed ID: 22924225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [An outpatient regimen for dental improvements in patients with valvular cardiopathies and oral anticoagulant therapy (a preliminary note)].
    Cesareo BV; Pettini M; Soreca G; Agostino R; Batoni L; Mancini G; Vannini AM; Sabatini L; Bertelli E
    Minerva Stomatol; 1994 Sep; 43(9):409-15. PubMed ID: 7816015
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypercoagulability and the management of anticoagulant therapy in surgical patients: review and recommendations.
    Nevarre DR; Digiovanni A
    J Endovasc Surg; 1998 Aug; 5(3):282-91. PubMed ID: 9761586
    [No Abstract]   [Full Text] [Related]  

  • 58. [Can the risk of atrial fibrillation due to pulmonary embolism be minimized by addition of a platelet aggregation inhibitor to an oral anticoagulant?].
    Ned Tijdschr Geneeskd; 1992 Sep; 136(36):1784. PubMed ID: 1407130
    [No Abstract]   [Full Text] [Related]  

  • 59. Anticoagulation: indications and risk classification schemes.
    Hawes EM; Viera AJ
    FP Essent; 2014 Jul; 422():11-7. PubMed ID: 25033001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Current status of antithrombotic therapy].
    Lengfelder W
    Dtsch Med Wochenschr; 1995 Jan; 120(4):105-10. PubMed ID: 7835235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.